Category: Therapeutic Area
Global Therapeutic Area
-
Narcolepsy Therapeutics
... at a CAGR of 7.2% over the analysis period 2023-2030. Narcolepsy with Cataplexy Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.9 Billion by the ... Read More
-
Orthopedic Devices
... at a CAGR of 6.3% over the analysis period 2023-2030. Joint Reconstruction Devices, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$44.6 Billion by the end ... Read More
-
EEG, EMG and Evoked Potential Devices
... the year 2023, is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Electroencephalograph Equipment, one of the segments analyzed in the report, is expected to ... Read More
-
Food Allergy and Intolerance Products
... is expected to reach US$53.9 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Lactose-Free Products, one of the segments analyzed in the report, is expected to record a 5.1% ... Read More
-
Overactive Bladder (OAB) Therapeutics
... reach US$1.5 Billion by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. Anticholinergics Therapy, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach ... Read More
-
Bone and Joint Health Supplements
... is expected to reach US$22.0 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Joint Supplements, one of the segments analyzed in the report, is expected to record a 6.3% ... Read More
-
Irritable Bowel Syndrome (IBS) Therapeutics
... is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. IBS-D Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% ... Read More
-
Peptic Ulcer Testing
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$410.6 Million by ... Read More
-
Breast Biopsy Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Biopsy Guidance Systems, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$983.4 Million ... Read More
-
Melanoma Therapeutics
... at a CAGR of 13.8% over the analysis period 2023-2030. Cutaneous Melanoma Therapeutics, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$4.3 Billion by the end ... Read More
-
Pediatric Drugs and Vaccines
... reach US$156.7 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2023-2030. Conjugate Technology, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach ... Read More
-
Cardiovascular Catheters
... at a CAGR of 6.5% over the analysis period 2023-2030. Cardiovascular Therapeutic Catheters, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$25.4 Billion by the end ... Read More
-
Gastrointestinal (GI) Endoscopy Devices
... reach US$49.9 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), one of the segments analyzed in the report, is expected to record a 5.3% ... Read More
-
Lymphoma Therapeutics
... at a CAGR of 6.6% over the analysis period 2023-2030. Non-Hodgkin Lymphoma (NHL) Therapeutics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$20.5 Billion by the ... Read More
-
Global Age-Related Macular Degeneration Market Forecast Report by Disease Type (Dry Age-Related Macular Degeneration Market, Wet Age-Related Macular Degeneration Market) Product (Eylea, Lucentis, Beovu, Others) Distribution Channel (Hospital Pharmacy, Specialty Pharma, Online Pharmacy) Countries and Company Analysis, 2024-2032
... Company Analysis, 2024-2032 Age-Related Macular Degeneration Market Analysis The Global Age-Related Macular Degeneration market is forecasted to reach US$ 19.53 billion by 2032 from US$ 10.68 billion in 2023, and compound annual growth rate of ... Read More
-
Lung Cancer Diagnostics
... by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Imaging Tests, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.3 Billion by ... Read More
-
Bladder Cancer Therapeutics
... by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Transitional Cell Bladder Cancer Therapeutics, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach ... Read More
-
Medical Exoskeleton Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Body Part Covered
... the forecast period 2024-2035. Medical exoskeletons, wearable robotic devices tailored to aid individuals with mobility impairments, harness a blend of mechanical, electronic, and computer-controlled systems to bolster and refine the user's movement. Typically, homing in ... Read More
-
Pain Management Drugs Market By Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Anti-migraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics) , By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Muscle Sprain/Strain, Bone Fracture, Acute Appendicitis, Others) By Pain Type (Chronic Pain, Acute Pain) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... Fracture, Acute Appendicitis, Others) By Pain Type (Chronic Pain, Acute Pain) : Global Opportunity Analysis and Industry Forecast, 2024-2033 Pain Management Drugs Market The pain management drugs market was valued at $72.6 billion in 2023 ... Read More
-
Hospital Emergency Department Market By Insurance Type (Medicare and Medicaid, Private and Others) , By Condition (Traumatic, Infectious, Gastrointestinal, Psychiatric, Cardiac, Neurologic, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... department market was valued at $135.0 billion in 2023, and is projected to reach $202.2 billion by 2033, growing at a CAGR of 4.1% from 2024 to 2033. The hospital emergency department (ED), often referred ... Read More
-
Photoacoustic Imaging Market by Product (Imaging System, Transducer, Software, Accessories), Technology (Microscopy, Tomography), Type (Preclinical, Clinical), Application (Oncology, Neuro), End User (Hospitals, Academia) & Region Global Forecast to 2029
... projected to reach USD 105 million by 2029 from USD 80 million in 2024, at a CAGR of 5.5% during the forecast period of 2024 to 2029. The market is experiencing an upward trend driven ... Read More
-
Acute Coronary Syndrome
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 16.4% CAGR The Acute Coronary Syndrome market ... Read More
-
Migraine Drugs
... at a CAGR of 16.1% over the analysis period 2023-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.7% CAGR and reach US$7.2 Billion by the end of ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics
... the year 2023, is expected to reach US$57.7 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Stimulant Drugs, one of the segments analyzed in the report, is expected to ... Read More
-
Chiropractic Care
... at a CAGR of 3.6% over the analysis period 2023-2030. Relief Care, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$25.6 Billion by the end of ... Read More
Research Assistance
